The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mesalamine Market Research Report 2020

Global Mesalamine Market Research Report 2020

Publishing Date : Apr, 2020

License Type :
 

Report Code : 1582339

No of Pages : 120

Synopsis
Mesalamine also known as Mesalazine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories and Cambrex Corporation, which accounted for 24.07%, 12.91% and 6.61% of revenues in 2019, respectively. In terms of regions, the revenue share in Europe is the highest, reaching 46.73% in 2019.
The global Mesalamine market is valued at US$ 134.6 million in 2019 is expected to reach US$ 181.6 million by the end of 2026, growing at a CAGR of 4.1% during 2020-2026.
QY Research has recently curated a research report titled, Global Mesalamine Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Mesalamine market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period.
Global Mesalamine Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Mesalamine Market: Segment Analysis
The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Mesalamine Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Mesalamine Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
According to the type, purity ≥ 98% is the highest, reaching 48.44% in 2019.
By Application:
Mesalazine Tablets
Mesalazine Capsules
Others
Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.
Key Players:
The Key manufacturers that are operating in the global Mesalamine market are:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Competitive Landscape
The analysts have provided a comprehensive analysis of the competitive landscape of the global Mesalamine market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Index
1 Mesalamine Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Mesalamine Segment by Type
1.2.1 Global Mesalamine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Mesalamine Segment by Application
1.3.1 Mesalamine Sales Comparison by Application: 2020 VS 2026
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2015-2026
1.4.2 Global Mesalamine Sales 2015-2026
1.4.3 Mesalamine Market Size by Region: 2020 Versus 2026

2 Global Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Mesalamine Revenue Share by Manufacturers (2015-2020)
2.3 Global Mesalamine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Mesalamine Manufacturing Sites, Area Served, Product Type
2.5 Mesalamine Market Competitive Situation and Trends
2.5.1 Mesalamine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Mesalamine Players (Opinion Leaders)

3 Mesalamine Retrospective Market Scenario by Region
3.1 Global Mesalamine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Mesalamine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Mesalamine Market Facts & Figures by Country
3.3.1 North America Mesalamine Sales by Country
3.3.2 North America Mesalamine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalamine Market Facts & Figures by Country
3.4.1 Europe Mesalamine Sales by Country
3.4.2 Europe Mesalamine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalamine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalamine Sales by Region
3.5.2 Asia Pacific Mesalamine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mesalamine Market Facts & Figures by Country
3.6.1 Latin America Mesalamine Sales by Country
3.6.2 Latin America Mesalamine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalamine Sales by Country
3.7.2 Middle East and Africa Mesalamine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Mesalamine Historic Market Analysis by Type
4.1 Global Mesalamine Sales Market Share by Type (2015-2020)
4.2 Global Mesalamine Revenue Market Share by Type (2015-2020)
4.3 Global Mesalamine Price Market Share by Type (2015-2020)
4.4 Global Mesalamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Mesalamine Historic Market Analysis by Application
5.1 Global Mesalamine Sales Market Share by Application (2015-2020)
5.2 Global Mesalamine Revenue Market Share by Application (2015-2020)
5.3 Global Mesalamine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Mesalamine Business
6.1 Syntese A/S
6.1.1 Corporation Information
6.1.2 Syntese A/S Description, Business Overview and Total Revenue
6.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Syntese A/S Products Offered
6.1.5 Syntese A/S Recent Development
6.2 Divis Laboratories
6.2.1 Divis Laboratories Mesalamine Production Sites and Area Served
6.2.2 Divis Laboratories Description, Business Overview and Total Revenue
6.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Divis Laboratories Products Offered
6.2.5 Divis Laboratories Recent Development
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Mesalamine Production Sites and Area Served
6.3.2 Cambrex Corporation Description, Business Overview and Total Revenue
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Cambrex Corporation Products Offered
6.3.5 Cambrex Corporation Recent Development
6.4 Ipca Laboratories
6.4.1 Ipca Laboratories Mesalamine Production Sites and Area Served
6.4.2 Ipca Laboratories Description, Business Overview and Total Revenue
6.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ipca Laboratories Products Offered
6.4.5 Ipca Laboratories Recent Development
6.5 PharmaZell
6.5.1 PharmaZell Mesalamine Production Sites and Area Served
6.5.2 PharmaZell Description, Business Overview and Total Revenue
6.5.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 PharmaZell Products Offered
6.5.5 PharmaZell Recent Development
6.6 Lasa Loboratory
6.6.1 Lasa Loboratory Mesalamine Production Sites and Area Served
6.6.2 Lasa Loboratory Description, Business Overview and Total Revenue
6.6.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lasa Loboratory Products Offered
6.6.5 Lasa Loboratory Recent Development
6.7 Erregierre SpA
6.6.1 Erregierre SpA Mesalamine Production Sites and Area Served
6.6.2 Erregierre SpA Description, Business Overview and Total Revenue
6.6.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Erregierre SpA Products Offered
6.7.5 Erregierre SpA Recent Development
6.8 Corden Pharma Bergamo
6.8.1 Corden Pharma Bergamo Mesalamine Production Sites and Area Served
6.8.2 Corden Pharma Bergamo Description, Business Overview and Total Revenue
6.8.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Corden Pharma Bergamo Products Offered
6.8.5 Corden Pharma Bergamo Recent Development
6.9 CTX Lifescience
6.9.1 CTX Lifescience Mesalamine Production Sites and Area Served
6.9.2 CTX Lifescience Description, Business Overview and Total Revenue
6.9.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 CTX Lifescience Products Offered
6.9.5 CTX Lifescience Recent Development
6.10 Ishita Active Pharma Ingredients
6.10.1 Ishita Active Pharma Ingredients Mesalamine Production Sites and Area Served
6.10.2 Ishita Active Pharma Ingredients Description, Business Overview and Total Revenue
6.10.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Ishita Active Pharma Ingredients Products Offered
6.10.5 Ishita Active Pharma Ingredients Recent Development
6.11 YC Biotech (Jiangsu)
6.11.1 YC Biotech (Jiangsu) Mesalamine Production Sites and Area Served
6.11.2 YC Biotech (Jiangsu) Mesalamine Description, Business Overview and Total Revenue
6.11.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 YC Biotech (Jiangsu) Products Offered
6.11.5 YC Biotech (Jiangsu) Recent Development
6.12 Xinxiang Tianfeng Fine Chemical
6.12.1 Xinxiang Tianfeng Fine Chemical Mesalamine Production Sites and Area Served
6.12.2 Xinxiang Tianfeng Fine Chemical Mesalamine Description, Business Overview and Total Revenue
6.12.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Xinxiang Tianfeng Fine Chemical Products Offered
6.12.5 Xinxiang Tianfeng Fine Chemical Recent Development

7 Mesalamine Manufacturing Cost Analysis
7.1 Mesalamine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalamine
7.4 Mesalamine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalamine Distributors List
8.3 Mesalamine Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Mesalamine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mesalamine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Mesalamine by Type (2021-2026)
10.2 Mesalamine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalamine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Mesalamine by Application (2021-2026)
10.3 Mesalamine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalamine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Mesalamine by Region (2021-2026)
10.4 North America Mesalamine Estimates and Projections (2021-2026)
10.5 Europe Mesalamine Estimates and Projections (2021-2026)
10.6 Asia Pacific Mesalamine Estimates and Projections (2021-2026)
10.7 Latin America Mesalamine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Mesalamine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Mesalamine Sales (Ton) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Mesalamine Sales (Ton) Comparison by Application: 2020 VS 2026
Table 3. Global Mesalamine Market Size by Type (Ton) (US$ Million) (2020 VS 2026)
Table 4. Global Key Mesalamine Manufacturers Covered in This Study
Table 5. Global Mesalamine Sales (Ton) by Manufacturers (2015-2020)
Table 6. Global Mesalamine Sales Share by Manufacturers (2015-2020)
Table 7. Global Mesalamine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Mesalamine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Mesalamine Average Price (US$/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Mesalamine Sales Sites and Area Served
Table 11. Manufacturers Mesalamine Product Types
Table 12. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Mesalamine Players
Table 16. Global Mesalamine Sales (Ton) by Region (2015-2020)
Table 17. Global Mesalamine Sales Market Share by Region (2015-2020)
Table 18. Global Mesalamine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Mesalamine Revenue Market Share by Region (2015-2020)
Table 20. North America Mesalamine Sales by Country (2015-2020) (Ton)
Table 21. North America Mesalamine Sales Market Share by Country (2015-2020)
Table 22. North America Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Mesalamine Revenue Market Share by Country (2015-2020)
Table 24. Europe Mesalamine Sales by Country (2015-2020) (Ton)
Table 25. Europe Mesalamine Sales Market Share by Country (2015-2020)
Table 26. Europe Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Mesalamine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Mesalamine Sales by Region (2015-2020) (Ton)
Table 29. Asia Pacific Mesalamine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Mesalamine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Mesalamine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Mesalamine Sales by Country (2015-2020) (Ton)
Table 33. Latin America Mesalamine Sales Market Share by Country (2015-2020)
Table 34. Latin America Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Mesalamine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Mesalamine Sales by Country (2015-2020) (Ton)
Table 37. Middle East and Africa Mesalamine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Mesalamine Revenue Market Share by Country (2015-2020)
Table 40. Global Mesalamine Sales (Ton) by Type (2015-2020)
Table 41. Global Mesalamine Sales Share by Type (2015-2020)
Table 42. Global Mesalamine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Mesalamine Revenue Share by Type (2015-2020)
Table 44. Global Mesalamine Price (US$/Kg) by Type (2015-2020)
Table 45. Global Mesalamine Sales (Ton) by Application (2015-2020)
Table 46. Global Mesalamine Sales Market Share by Application (2015-2020)
Table 47. Global Mesalamine Sales Growth Rate by Application (2015-2020)
Table 48. Syntese A/S Mesalamine Corporation Information
Table 49. Syntese A/S Description and Business Overview
Table 50. Syntese A/S Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 51. Syntese A/S Main Product
Table 52. Syntese A/S Recent Development
Table 53. Divis Laboratories Mesalamine Corporation Information
Table 54. Divis Laboratories Corporation Information
Table 55. Divis Laboratories Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 56. Divis Laboratories Main Product
Table 57. Divis Laboratories Recent Development
Table 58. Cambrex Corporation Mesalamine Corporation Information
Table 59. Cambrex Corporation Corporation Information
Table 60. Cambrex Corporation Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 61. Cambrex Corporation Main Product
Table 62. Cambrex Corporation Recent Development
Table 63. Ipca Laboratories Mesalamine Corporation Information
Table 64. Ipca Laboratories Corporation Information
Table 65. Ipca Laboratories Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 66. Ipca Laboratories Main Product
Table 67. Ipca Laboratories Recent Development
Table 68. PharmaZell Mesalamine Corporation Information
Table 69. PharmaZell Corporation Information
Table 70. PharmaZell Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 71. PharmaZell Main Product
Table 72. PharmaZell Recent Development
Table 73. Lasa Loboratory Mesalamine Corporation Information
Table 74. Lasa Loboratory Corporation Information
Table 75. Lasa Loboratory Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 76. Lasa Loboratory Main Product
Table 77. Lasa Loboratory Recent Development
Table 78. Erregierre SpA Mesalamine Corporation Information
Table 79. Erregierre SpA Corporation Information
Table 80. Erregierre SpA Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 81. Erregierre SpA Main Product
Table 82. Erregierre SpA Recent Development
Table 83. Corden Pharma Bergamo Mesalamine Corporation Information
Table 84. Corden Pharma Bergamo Corporation Information
Table 85. Corden Pharma Bergamo Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 86. Corden Pharma Bergamo Main Product
Table 87. Corden Pharma Bergamo Recent Development
Table 88. CTX Lifescience Mesalamine Corporation Information
Table 89. CTX Lifescience Corporation Information
Table 90. CTX Lifescience Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 91. CTX Lifescience Main Product
Table 92. CTX Lifescience Recent Development
Table 93. Ishita Active Pharma Ingredients Mesalamine Corporation Information
Table 94. Ishita Active Pharma Ingredients Corporation Information
Table 95. Ishita Active Pharma Ingredients Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 96. Ishita Active Pharma Ingredients Main Product
Table 97. Ishita Active Pharma Ingredients Recent Development
Table 98. YC Biotech (Jiangsu) Mesalamine Corporation Information
Table 99. YC Biotech (Jiangsu) Corporation Information
Table 100. YC Biotech (Jiangsu) Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 101. YC Biotech (Jiangsu) Main Product
Table 102. YC Biotech (Jiangsu) Recent Development
Table 103. Xinxiang Tianfeng Fine Chemical Mesalamine Corporation Information
Table 104. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 105. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 106. Xinxiang Tianfeng Fine Chemical Main Product
Table 107. Xinxiang Tianfeng Fine Chemical Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Mesalamine Distributors List
Table 111. Mesalamine Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Mesalamine Sales (Ton) Forecast by Type (2021-2026)
Table 116. Global Mesalamine Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Mesalamine Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Mesalamine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Mesalamine Sales (Ton) Forecast by Application (2021-2026)
Table 120. Global Mesalamine Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Mesalamine Sales (Ton) Forecast by Region (2021-2026)
Table 122. Global Mesalamine Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Mesalamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Mesalamine Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Mesalamine
Figure 2. Global Mesalamine Sales Market Share by Type: 2020 VS 2026
Figure 3. Purity ≥ 97 % Product Picture
Figure 4. Purity ≥ 98 % Product Picture
Figure 5. Purity ≥ 99 % Product Picture
Figure 6. Global Mesalamine Consumption Market Share by Application: 2020 VS 2026
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Global Mesalamine Market Size 2015-2026 (US$ Million)
Figure 11. Global Mesalamine Sales Capacity (Ton) (2015-2026)
Figure 12. Global Mesalamine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Mesalamine Sales Share by Manufacturers in 2020
Figure 14. Global Mesalamine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Mesalamine Revenue in 2019
Figure 16. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Mesalamine Sales Market Share by Region (2015-2020)
Figure 18. Global Mesalamine Sales Market Share by Region in 2019
Figure 19. Global Mesalamine Revenue Market Share by Region (2015-2020)
Figure 20. Global Mesalamine Revenue Market Share by Region in 2019
Figure 21. North America Mesalamine Sales Market Share by Country in 2019
Figure 22. North America Mesalamine Revenue Market Share by Country in 2019
Figure 23. U.S. Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 24. U.S. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 26. Canada Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Mesalamine Sales Market Share by Country in 2019
Figure 28. Europe Mesalamine Revenue Market Share by Country in 2019
Figure 29. Germany Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 30. Germany Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 32. France Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 34. U.K. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 36. Italy Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 38. Russia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Mesalamine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Mesalamine Revenue Market Share by Region in 2019
Figure 41. China Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 42. China Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 44. Japan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 46. South Korea Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 48. India Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 50. Australia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 52. Taiwan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 54. Indonesia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 56. Thailand Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 58. Malaysia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 60. Philippines Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 62. Vietnam Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Mesalamine Sales Market Share by Country in 2019
Figure 64. Latin America Mesalamine Revenue Market Share by Country in 2019
Figure 65. Mexico Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 66. Mexico Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 68. Brazil Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 70. Argentina Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Mesalamine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Mesalamine Revenue Market Share by Country in 2019
Figure 73. Turkey Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 74. Turkey Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 76. Saudi Arabia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 78. U.A.E Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Mesalamine by Type (2015-2020)
Figure 80. Sales Market Share of Mesalamine by Type in 2019
Figure 81. Revenue Share of Mesalamine by Type (2015-2020)
Figure 82. Revenue Market Share of Mesalamine by Type in 2019
Figure 83. Global Mesalamine Sales Growth by Type (2015-2020) (Ton)
Figure 84. Global Mesalamine Sales Market Share by Application (2015-2020)
Figure 85. Global Mesalamine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Mesalamine by Application (2015-2020)
Figure 87. Global Revenue Share of Mesalamine by Application in 2020
Figure 88. Syntese A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Divis Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Cambrex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. PharmaZell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Lasa Loboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Erregierre SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Corden Pharma Bergamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CTX Lifescience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ishita Active Pharma Ingredients Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. YC Biotech (Jiangsu) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Xinxiang Tianfeng Fine Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Mesalamine
Figure 102. Manufacturing Process Analysis of Mesalamine
Figure 103. Mesalamine Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Mesalamine Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 108. North America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Mesalamine Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Mesalamine Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Mesalamine Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Mesalamine Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’